MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Lyme
Ionica Sciences
Attachments
IonLyme - Innovative Testing for Lyme Disease by Ionica Sciences
Parents
*Architects / Consolidators: Infectious Disease_Coronavirus (Covid-19)
*Industry: New York
2022: TechConnect_Medical Innovation Challenge_September 2022
Architects: Lyme
Children
Combining a highly sensitive spectroscopic method, and a highly selective method to identify proteins associated with the targeted disease, the IonID platform will serve as the third pillar of diagnostic testing.
Founded 2013
Ionica Sciences™ has developed a new technology platform to meet urgent needs for a variety of clinical diagnostics such as Lyme disease, COVID, mosquito-borne diseases and STIs.
Ithaca, New York
The IonID diagnostic platform for infectious diseases and medical conditions
The IonID is a diagnostic platform that addresses diseases that are poorly served by PCR or antigen testing.